← All trials
NCT04528680
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 31, 2020
- Primary completion
- Aug 31, 2024
- Completion date
- Sep 30, 2025
- First posted
- Aug 27, 2020
- Last posted
- Oct 12, 2020
- Enrollment
- 39
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Northwestern UniversityLead sponsor
- CarTheraCollaborator
- Lantheus Medical ImagingCollaborator
- Northwestern UniversityOverall official - principal investigator
- Northwestern UniversityReponsible party - principal investigator
- Northwestern UniversityStudy chair
- Northwestern UniversitySponsor investigator
- Bristol-Myers SquibbCollaborator
- Northwestern UniversityOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.